The global market for Trastuzumab Biosimilars was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Trastuzumab is used for the treatment of HER2-positive early breast cancer, metastatic breast cancer and metastatic gastric cancer.

North American market for Trastuzumab Biosimilars is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Trastuzumab Biosimilars is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Trastuzumab Biosimilars include Fosun International Limited, Anhui Anke Bioengineering, Hisun Biopharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Genentech Inc, Daiichi Sankyo, Pfizer, Celltrion Healthcare, Baxter Oncology GmbH, Sandoz, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Trastuzumab Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Biosimilars.

The Trastuzumab Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Trastuzumab Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Trastuzumab Biosimilars manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Trastuzumab Biosimilars Market Report

Report Metric	Details
Report Name	Trastuzumab Biosimilars Market
Segment by Type	Humanized Trastuzumab Animal-derived Trastuzumab
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Fosun International Limited, Anhui Anke Bioengineering, Hisun Biopharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Genentech Inc, Daiichi Sankyo, Pfizer, Celltrion Healthcare, Baxter Oncology GmbH, Sandoz
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Trastuzumab Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Trastuzumab Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Trastuzumab Biosimilars Market report?

Ans: The main players in the Trastuzumab Biosimilars Market are Fosun International Limited, Anhui Anke Bioengineering, Hisun Biopharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Genentech Inc, Daiichi Sankyo, Pfizer, Celltrion Healthcare, Baxter Oncology GmbH, Sandoz

What are the Application segmentation covered in the Trastuzumab Biosimilars Market report?

Ans: The Applications covered in the Trastuzumab Biosimilars Market report are Hospital, Clinic

What are the Type segmentation covered in the Trastuzumab Biosimilars Market report?

Ans: The Types covered in the Trastuzumab Biosimilars Market report are Humanized Trastuzumab, Animal-derived Trastuzumab

1 Trastuzumab Biosimilars Market Overview

1.1 Product Definition

1.2 Trastuzumab Biosimilars by Type

1.2.1 Global Trastuzumab Biosimilars Market Value Comparison by Type (2024 VS 2031)

1.2.2 Humanized Trastuzumab

1.2.3 Animal-derived Trastuzumab

1.3 Trastuzumab Biosimilars by Application

1.3.1 Global Trastuzumab Biosimilars Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Trastuzumab Biosimilars Market Size Estimates and Forecasts

1.4.1 Global Trastuzumab Biosimilars Revenue 2020-2031

1.4.2 Global Trastuzumab Biosimilars Sales 2020-2031

1.4.3 Global Trastuzumab Biosimilars Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Trastuzumab Biosimilars Market Competition by Manufacturers

2.1 Global Trastuzumab Biosimilars Sales Market Share by Manufacturers (2020-2025)

2.2 Global Trastuzumab Biosimilars Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Trastuzumab Biosimilars Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Trastuzumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Trastuzumab Biosimilars, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Trastuzumab Biosimilars, Product Type & Application

2.7 Global Key Manufacturers of Trastuzumab Biosimilars, Date of Enter into This Industry

2.8 Global Trastuzumab Biosimilars Market Competitive Situation and Trends

2.8.1 Global Trastuzumab Biosimilars Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Trastuzumab Biosimilars Players Market Share by Revenue

2.8.3 Global Trastuzumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Trastuzumab Biosimilars Market Scenario by Region

3.1 Global Trastuzumab Biosimilars Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Trastuzumab Biosimilars Sales by Region: 2020-2031

3.2.1 Global Trastuzumab Biosimilars Sales by Region: 2020-2025

3.2.2 Global Trastuzumab Biosimilars Sales by Region: 2026-2031

3.3 Global Trastuzumab Biosimilars Revenue by Region: 2020-2031

3.3.1 Global Trastuzumab Biosimilars Revenue by Region: 2020-2025

3.3.2 Global Trastuzumab Biosimilars Revenue by Region: 2026-2031

3.4 North America Trastuzumab Biosimilars Market Facts & Figures by Country

3.4.1 North America Trastuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Trastuzumab Biosimilars Sales by Country (2020-2031)

3.4.3 North America Trastuzumab Biosimilars Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Trastuzumab Biosimilars Market Facts & Figures by Country

3.5.1 Europe Trastuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Trastuzumab Biosimilars Sales by Country (2020-2031)

3.5.3 Europe Trastuzumab Biosimilars Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Trastuzumab Biosimilars Market Facts & Figures by Region

3.6.1 Asia Pacific Trastuzumab Biosimilars Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Trastuzumab Biosimilars Sales by Region (2020-2031)

3.6.3 Asia Pacific Trastuzumab Biosimilars Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Trastuzumab Biosimilars Market Facts & Figures by Country

3.7.1 Latin America Trastuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Trastuzumab Biosimilars Sales by Country (2020-2031)

3.7.3 Latin America Trastuzumab Biosimilars Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Trastuzumab Biosimilars Market Facts & Figures by Country

3.8.1 Middle East and Africa Trastuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Trastuzumab Biosimilars Sales by Country (2020-2031)

3.8.3 Middle East and Africa Trastuzumab Biosimilars Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Trastuzumab Biosimilars Sales by Type (2020-2031)

4.1.1 Global Trastuzumab Biosimilars Sales by Type (2020-2025)

4.1.2 Global Trastuzumab Biosimilars Sales by Type (2026-2031)

4.1.3 Global Trastuzumab Biosimilars Sales Market Share by Type (2020-2031)

4.2 Global Trastuzumab Biosimilars Revenue by Type (2020-2031)

4.2.1 Global Trastuzumab Biosimilars Revenue by Type (2020-2025)

4.2.2 Global Trastuzumab Biosimilars Revenue by Type (2026-2031)

4.2.3 Global Trastuzumab Biosimilars Revenue Market Share by Type (2020-2031)

4.3 Global Trastuzumab Biosimilars Price by Type (2020-2031)

5 Segment by Application

5.1 Global Trastuzumab Biosimilars Sales by Application (2020-2031)

5.1.1 Global Trastuzumab Biosimilars Sales by Application (2020-2025)

5.1.2 Global Trastuzumab Biosimilars Sales by Application (2026-2031)

5.1.3 Global Trastuzumab Biosimilars Sales Market Share by Application (2020-2031)

5.2 Global Trastuzumab Biosimilars Revenue by Application (2020-2031)

5.2.1 Global Trastuzumab Biosimilars Revenue by Application (2020-2025)

5.2.2 Global Trastuzumab Biosimilars Revenue by Application (2026-2031)

5.2.3 Global Trastuzumab Biosimilars Revenue Market Share by Application (2020-2031)

5.3 Global Trastuzumab Biosimilars Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Fosun International Limited

6.1.1 Fosun International Limited Company Information

6.1.2 Fosun International Limited Description and Business Overview

6.1.3 Fosun International Limited Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Fosun International Limited Trastuzumab Biosimilars Product Portfolio

6.1.5 Fosun International Limited Recent Developments/Updates

6.2 Anhui Anke Bioengineering

6.2.1 Anhui Anke Bioengineering Company Information

6.2.2 Anhui Anke Bioengineering Description and Business Overview

6.2.3 Anhui Anke Bioengineering Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Anhui Anke Bioengineering Trastuzumab Biosimilars Product Portfolio

6.2.5 Anhui Anke Bioengineering Recent Developments/Updates

6.3 Hisun Biopharmaceuticals

6.3.1 Hisun Biopharmaceuticals Company Information

6.3.2 Hisun Biopharmaceuticals Description and Business Overview

6.3.3 Hisun Biopharmaceuticals Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Hisun Biopharmaceuticals Trastuzumab Biosimilars Product Portfolio

6.3.5 Hisun Biopharmaceuticals Recent Developments/Updates

6.4 Chia Tai Tianqing Pharmaceutical Group

6.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information

6.4.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview

6.4.3 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Product Portfolio

6.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates

6.5 Genentech Inc

6.5.1 Genentech Inc Company Information

6.5.2 Genentech Inc Description and Business Overview

6.5.3 Genentech Inc Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Genentech Inc Trastuzumab Biosimilars Product Portfolio

6.5.5 Genentech Inc Recent Developments/Updates

6.6 Daiichi Sankyo

6.6.1 Daiichi Sankyo Company Information

6.6.2 Daiichi Sankyo Description and Business Overview

6.6.3 Daiichi Sankyo Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Daiichi Sankyo Trastuzumab Biosimilars Product Portfolio

6.6.5 Daiichi Sankyo Recent Developments/Updates

6.7 Pfizer

6.7.1 Pfizer Company Information

6.7.2 Pfizer Description and Business Overview

6.7.3 Pfizer Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Pfizer Trastuzumab Biosimilars Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Celltrion Healthcare

6.8.1 Celltrion Healthcare Company Information

6.8.2 Celltrion Healthcare Description and Business Overview

6.8.3 Celltrion Healthcare Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Celltrion Healthcare Trastuzumab Biosimilars Product Portfolio

6.8.5 Celltrion Healthcare Recent Developments/Updates

6.9 Baxter Oncology GmbH

6.9.1 Baxter Oncology GmbH Company Information

6.9.2 Baxter Oncology GmbH Description and Business Overview

6.9.3 Baxter Oncology GmbH Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Baxter Oncology GmbH Trastuzumab Biosimilars Product Portfolio

6.9.5 Baxter Oncology GmbH Recent Developments/Updates

6.10 Sandoz

6.10.1 Sandoz Company Information

6.10.2 Sandoz Description and Business Overview

6.10.3 Sandoz Trastuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Sandoz Trastuzumab Biosimilars Product Portfolio

6.10.5 Sandoz Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Trastuzumab Biosimilars Industry Chain Analysis

7.2 Trastuzumab Biosimilars Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Trastuzumab Biosimilars Production Mode & Process Analysis

7.4 Trastuzumab Biosimilars Sales and Marketing

7.4.1 Trastuzumab Biosimilars Sales Channels

7.4.2 Trastuzumab Biosimilars Distributors

7.5 Trastuzumab Biosimilars Customer Analysis

8 Trastuzumab Biosimilars Market Dynamics

8.1 Trastuzumab Biosimilars Industry Trends

8.2 Trastuzumab Biosimilars Market Drivers

8.3 Trastuzumab Biosimilars Market Challenges

8.4 Trastuzumab Biosimilars Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Chia Tai Tianqing Pharmaceutical Group

Hisun Biopharmaceuticals

Baxter Oncology GmbH

List of Tables

Table 1. Global Trastuzumab Biosimilars Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Trastuzumab Biosimilars Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Trastuzumab Biosimilars Market Competitive Situation by Manufacturers in 2024

Table 4. Global Trastuzumab Biosimilars Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Trastuzumab Biosimilars Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Trastuzumab Biosimilars Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Trastuzumab Biosimilars Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Trastuzumab Biosimilars Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Trastuzumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Trastuzumab Biosimilars, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Trastuzumab Biosimilars, Product Type & Application

Table 12. Global Key Manufacturers of Trastuzumab Biosimilars, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Trastuzumab Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab Biosimilars as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Trastuzumab Biosimilars Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Trastuzumab Biosimilars Sales by Region (2020-2025) & (K Units)

Table 18. Global Trastuzumab Biosimilars Sales Market Share by Region (2020-2025)

Table 19. Global Trastuzumab Biosimilars Sales by Region (2026-2031) & (K Units)

Table 20. Global Trastuzumab Biosimilars Sales Market Share by Region (2026-2031)

Table 21. Global Trastuzumab Biosimilars Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Trastuzumab Biosimilars Revenue Market Share by Region (2020-2025)

Table 23. Global Trastuzumab Biosimilars Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Trastuzumab Biosimilars Revenue Market Share by Region (2026-2031)

Table 25. North America Trastuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Trastuzumab Biosimilars Sales by Country (2020-2025) & (K Units)

Table 27. North America Trastuzumab Biosimilars Sales by Country (2026-2031) & (K Units)

Table 28. North America Trastuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Trastuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Trastuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Trastuzumab Biosimilars Sales by Country (2020-2025) & (K Units)

Table 32. Europe Trastuzumab Biosimilars Sales by Country (2026-2031) & (K Units)

Table 33. Europe Trastuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Trastuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Trastuzumab Biosimilars Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Trastuzumab Biosimilars Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Trastuzumab Biosimilars Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Trastuzumab Biosimilars Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Trastuzumab Biosimilars Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Trastuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Trastuzumab Biosimilars Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Trastuzumab Biosimilars Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Trastuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Trastuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Trastuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Trastuzumab Biosimilars Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Trastuzumab Biosimilars Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Trastuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Trastuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Trastuzumab Biosimilars Sales (K Units) by Type (2020-2025)

Table 51. Global Trastuzumab Biosimilars Sales (K Units) by Type (2026-2031)

Table 52. Global Trastuzumab Biosimilars Sales Market Share by Type (2020-2025)

Table 53. Global Trastuzumab Biosimilars Sales Market Share by Type (2026-2031)

Table 54. Global Trastuzumab Biosimilars Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Trastuzumab Biosimilars Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Trastuzumab Biosimilars Revenue Market Share by Type (2020-2025)

Table 57. Global Trastuzumab Biosimilars Revenue Market Share by Type (2026-2031)

Table 58. Global Trastuzumab Biosimilars Price (US$/Unit) by Type (2020-2025)

Table 59. Global Trastuzumab Biosimilars Price (US$/Unit) by Type (2026-2031)

Table 60. Global Trastuzumab Biosimilars Sales (K Units) by Application (2020-2025)

Table 61. Global Trastuzumab Biosimilars Sales (K Units) by Application (2026-2031)

Table 62. Global Trastuzumab Biosimilars Sales Market Share by Application (2020-2025)

Table 63. Global Trastuzumab Biosimilars Sales Market Share by Application (2026-2031)

Table 64. Global Trastuzumab Biosimilars Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Trastuzumab Biosimilars Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Trastuzumab Biosimilars Revenue Market Share by Application (2020-2025)

Table 67. Global Trastuzumab Biosimilars Revenue Market Share by Application (2026-2031)

Table 68. Global Trastuzumab Biosimilars Price (US$/Unit) by Application (2020-2025)

Table 69. Global Trastuzumab Biosimilars Price (US$/Unit) by Application (2026-2031)

Table 70. Fosun International Limited Company Information

Table 71. Fosun International Limited Description and Business Overview

Table 72. Fosun International Limited Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Fosun International Limited Trastuzumab Biosimilars Product

Table 74. Fosun International Limited Recent Developments/Updates

Table 75. Anhui Anke Bioengineering Company Information

Table 76. Anhui Anke Bioengineering Description and Business Overview

Table 77. Anhui Anke Bioengineering Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Anhui Anke Bioengineering Trastuzumab Biosimilars Product

Table 79. Anhui Anke Bioengineering Recent Developments/Updates

Table 80. Hisun Biopharmaceuticals Company Information

Table 81. Hisun Biopharmaceuticals Description and Business Overview

Table 82. Hisun Biopharmaceuticals Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Hisun Biopharmaceuticals Trastuzumab Biosimilars Product

Table 84. Hisun Biopharmaceuticals Recent Developments/Updates

Table 85. Chia Tai Tianqing Pharmaceutical Group Company Information

Table 86. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview

Table 87. Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Product

Table 89. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates

Table 90. Genentech Inc Company Information

Table 91. Genentech Inc Description and Business Overview

Table 92. Genentech Inc Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Genentech Inc Trastuzumab Biosimilars Product

Table 94. Genentech Inc Recent Developments/Updates

Table 95. Daiichi Sankyo Company Information

Table 96. Daiichi Sankyo Description and Business Overview

Table 97. Daiichi Sankyo Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Daiichi Sankyo Trastuzumab Biosimilars Product

Table 99. Daiichi Sankyo Recent Developments/Updates

Table 100. Pfizer Company Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Pfizer Trastuzumab Biosimilars Product

Table 104. Pfizer Recent Developments/Updates

Table 105. Celltrion Healthcare Company Information

Table 106. Celltrion Healthcare Description and Business Overview

Table 107. Celltrion Healthcare Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Celltrion Healthcare Trastuzumab Biosimilars Product

Table 109. Celltrion Healthcare Recent Developments/Updates

Table 110. Baxter Oncology GmbH Company Information

Table 111. Baxter Oncology GmbH Description and Business Overview

Table 112. Baxter Oncology GmbH Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Baxter Oncology GmbH Trastuzumab Biosimilars Product

Table 114. Baxter Oncology GmbH Recent Developments/Updates

Table 115. Sandoz Company Information

Table 116. Sandoz Description and Business Overview

Table 117. Sandoz Trastuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Sandoz Trastuzumab Biosimilars Product

Table 119. Sandoz Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Trastuzumab Biosimilars Distributors List

Table 123. Trastuzumab Biosimilars Customers List

Table 124. Trastuzumab Biosimilars Market Trends

Table 125. Trastuzumab Biosimilars Market Drivers

Table 126. Trastuzumab Biosimilars Market Challenges

Table 127. Trastuzumab Biosimilars Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Trastuzumab Biosimilars

Figure 2. Global Trastuzumab Biosimilars Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Trastuzumab Biosimilars Market Share by Type: 2024 & 2031

Figure 4. Humanized Trastuzumab Product Picture

Figure 5. Animal-derived Trastuzumab Product Picture

Figure 6. Global Trastuzumab Biosimilars Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Trastuzumab Biosimilars Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Global Trastuzumab Biosimilars Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Trastuzumab Biosimilars Market Size (2020-2031) & (US$ Million)

Figure 12. Global Trastuzumab Biosimilars Sales (2020-2031) & (K Units)

Figure 13. Global Trastuzumab Biosimilars Average Price (US$/Unit) & (2020-2031)

Figure 14. Trastuzumab Biosimilars Report Years Considered

Figure 15. Trastuzumab Biosimilars Sales Share by Manufacturers in 2024

Figure 16. Global Trastuzumab Biosimilars Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Trastuzumab Biosimilars Players: Market Share by Revenue in Trastuzumab Biosimilars in 2024

Figure 18. Trastuzumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Trastuzumab Biosimilars Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Trastuzumab Biosimilars Sales Market Share by Country (2020-2031)

Figure 21. North America Trastuzumab Biosimilars Revenue Market Share by Country (2020-2031)

Figure 22. United States Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Trastuzumab Biosimilars Sales Market Share by Country (2020-2031)

Figure 25. Europe Trastuzumab Biosimilars Revenue Market Share by Country (2020-2031)

Figure 26. Germany Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Trastuzumab Biosimilars Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Trastuzumab Biosimilars Revenue Market Share by Region (2020-2031)

Figure 33. China Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Trastuzumab Biosimilars Sales Market Share by Country (2020-2031)

Figure 41. Latin America Trastuzumab Biosimilars Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa Trastuzumab Biosimilars Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa Trastuzumab Biosimilars Revenue Market Share by Country (2020-2031)

Figure 47. Turkey Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE Trastuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of Trastuzumab Biosimilars by Type (2020-2031)

Figure 51. Global Revenue Market Share of Trastuzumab Biosimilars by Type (2020-2031)

Figure 52. Global Trastuzumab Biosimilars Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of Trastuzumab Biosimilars by Application (2020-2031)

Figure 54. Global Revenue Market Share of Trastuzumab Biosimilars by Application (2020-2031)

Figure 55. Global Trastuzumab Biosimilars Price (US$/Unit) by Application (2020-2031)

Figure 56. Trastuzumab Biosimilars Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions